tiprankstipranks
Trending News
More News >
Vivoryon Therapeutics AG (DE:05Y)
:05Y
Germany Market

Vivoryon Therapeutics AG (05Y) Income Statement

Compare
36 Followers

Vivoryon Therapeutics AG Income Statement

Last quarter (Q2 2025), Vivoryon Therapeutics AG's total revenue was €0.00, a decrease of ― from the same quarter last year. In Q2, Vivoryon Therapeutics AG's net income was €-5.47M. See Vivoryon Therapeutics AG’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
€ 0.00€ -3.62M€ 0.00€ 10.76M€ 0.00
Gross Profit
€ -147.00K€ -3.10M€ -161.00K€ 9.03M€ -146.00K
Operating Expenses
€ 20.81M€ 25.74M€ 28.97M€ 21.84M€ 15.87M
Depreciation and Amortization
€ 147.00K€ 167.00K€ 161.00K€ 165.00K€ 146.00K
EBITDA
€ -20.34M€ -28.35M€ -28.17M€ -12.03M€ -16.34M
Operating Income
€ -20.96M€ -28.84M€ -29.13M€ -12.81M€ -16.02M
Other Income/Expenses
€ 393.00K€ 261.00K€ 777.00K€ 575.00K€ -493.00K
Pretax Income
€ -20.57M€ -28.58M€ -28.36M€ -12.22M€ -16.51M
Net Income
€ -20.57M€ -28.34M€ -28.16M€ -12.65M€ -16.51M
Per Share Metrics
Basic EPS
€ -0.79€ -1.12€ -1.28€ -0.63€ -0.83
Diluted EPS
€ -0.79€ -1.12€ -1.28€ -0.63€ -0.83
Weighted Average Shares Outstanding
26.04M 25.24M 22.02M 20.00M 19.98M
Weighted Average Shares Outstanding (Diluted)
26.04M 25.24M 22.02M 20.00M 19.98M
Currency in EUR

Vivoryon Therapeutics AG Earnings and Revenue History